Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France"
Eur J Obstet Gynecol Reprod Biol X
.
2024 Aug 2:23:100331.
doi: 10.1016/j.eurox.2024.100331.
eCollection 2024 Sep.
Authors
Matthieu Lehmann
1
,
Jean-Luc Pouly
2
,
Paul Barrière
3
,
Lauren Amy Boland
4
,
Samuel George Bean
4
,
Julian Jenkins
1
Affiliations
1
Gedeon Richter Suisse, Chemin des Mines 2, 1202 Geneva, Switzerland.
2
Université de Clermont Auvergne Faculté de médecine, 28 place Henri Dunant, 63000 Clermont Ferrand, France.
3
Nantes Université, CR2TI UMR 1064, CHU Nantes, 44093 Nantes Cedex, France.
4
Remap Consulting GmbH, Industrie Strasse 47, Postfach 7461, 6302 Zug, Switzerland.
PMID:
39220093
PMCID:
PMC11362636
DOI:
10.1016/j.eurox.2024.100331
No abstract available